Drug factory · FDA FEI 3002807539
Melbourn Scientific Limited trading as Intertek Melbourn
Saxon Way, Melbourn, United Kingdom
Problems found, fixed voluntarily at FDA's last inspection, Jun 30, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
7 drug inspections on record since 2009: 3 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Metoclopramide | Tests it | Evoke Pharma, Inc. | 72089-307 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 30, 2023 | Problems found, fixed voluntarily | Bioresearch Monitoring | — |
| Jun 16, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 29, 2019 | Problems found, fixed voluntarily | Bioresearch Monitoring | — |
| Nov 29, 2019 | Problems found, fixed voluntarily | Bioresearch Monitoring | — |
| Nov 1, 2016 | No problems found | Drug Quality Assurance | — |
| Jul 23, 2012 | No problems found | Drug Quality Assurance | — |
| Aug 11, 2009 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis.